IOBTQ (IO Biotech) Common Stock: $0.07 Mil (As of Sep. 2025)


What is IO Biotech Common Stock?

IO Biotech IOBTQ +27.50% Common Stock is $0.07 Mil as of Sep. 2025. The stock has 1 warning sign investors should review.

IO Biotech's quarterly common stock stayed the same from Mar. 2025 ($0.07 Mil) to Jun. 2025 ($0.07 Mil) but then increased from Jun. 2025 ($0.07 Mil) to Sep. 2025 ($0.07 Mil).

IO Biotech's annual common stock increased from Dec. 2022 ($0.03 Mil) to Dec. 2023 ($0.07 Mil) but then stayed the same from Dec. 2023 ($0.07 Mil) to Dec. 2024 ($0.07 Mil).

IO Biotech Common Stock Historical Data

* Premium members only.

The historical data trend for IO Biotech's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IO Biotech Common Stock Chart

IO Biotech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial 0.03 0.03 0.03 0.07 0.07

IO Biotech Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.07 0.07 0.07 0.07

IO Biotech Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.07 Mil mean?
IO Biotech (IOBTQ) has a Common Stock of $0.07 Mil as of Sep. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on IO Biotech and its competitors.
Is IO Biotech's Common Stock too high?
IO Biotech's current Common Stock is $0.07 Mil.
How does IO Biotech's Common Stock compare to CNBX and ENDV?
IO Biotech's Common Stock of $0.07 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on IO Biotech and its competitors. IO Biotech's current Common Stock is $0.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IO Biotech stock overvalued right now?
IO Biotech (IOBTQ) has a current Common Stock of $0.07 Mil. The current Common Stock is $0.07 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For IO Biotech (IOBTQ), the current Common Stock is $0.07 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IO Biotech Business Description

Address Ole Maaloes Vej 3, Copenhagen N, DNK, DK-2200
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.